drugset / Trial / NCT02096341
A Phase 1 Pilot Study of the Subcutaneous (s.c.) Route to Facilitate the Administration of RRx-001
NaSingle-groupOpen-labelTreatment
Summary
To investigate the dosage of RRx-001 by the subcutaneous route.
Timeline
- Start
- 2014-04
- Primary completion
- 2016-01
- Completion
- 2016-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NIBROZETONE | Other / unclassified | 16 mg/m2 | Subcutaneous |
| Subject | NIBROZETONE | Other / unclassified | 27 mg/m2 | Subcutaneous |